View Post

Dr. Synofzik's ARSACS study to be published in the Journal of Neurology

In Activities by ARSACS

“Speech treatment improves dysarthria in multisystemic ataxia: a raterblinded, controlled pilot-study in ARSACS” research study done by Dr. Synofzik and his research team to be published in the Journal of Neurology. To learn more about the study, interested readers can contact Dr. Matthis Synofzik directly. See Abstract Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec …

View Post

EMG data obtained from 35 ARSACS individuals

In Activities by ARSACS

EMG data of 6 muscles from 35 ARSACS patients were obtained as part of Dr. Luc J. Hébert’s ARSACS research project. The analysis of these EMG data will help to better understand the problem of spasticity in ARSACS patients and could eventually open the door to new interventions targeted more on these neuro- locomotive deficiences. Interesting, right? Share with your …

View Post

Learning from the UNC Catalyst for Rare Diseases

In Activities by ARSACS

The University of North Carolina (UNC) Catalyst for Rare Diseases, funded in 2016, was established as a precompetitive open research group with a mission to understand the functional phenotic manifestations of genetic mutations. This article describes the initial experiences and learning from the UNC Catalyst for Rare diseases. Interesting, right? Share with your friends & followers / Intéressant, non? Partagez …

View Post

Invitation to discover the « New insights into cerebellar disorders »

In Activities by ARSACS

Opportunity to meet Dr. Esther Becker from University of Oxford guest speaker at the NeuroForum 2019 conference and find out the «New insights into cerebellar disorders». The conference, organised by the Axe NeuroSciences, Centre de Recherche du CHU de Québec, will be held on Thursday 25,2019 at 11:00am at the LOEX site HEJ (Local R-138) and projected at the Amphithéâtre …

View Post

Dr. Watt's research – understanding the cerebellum

In Activities by ARSACS

Dr. Alanna Watt talks about her lab’s research in understanding the cerebellum and the cellular changes that contribute to ARSACS in order to develop therapeutics. Presentation. Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec vos amis:

View Post

SacsR272C missense homozygous mice develop an ataxia phenotype

In Activities by ARSACS

The research of Dr. Roxanne Larivière and her team supports that Sacs missense mutation largely leads to loss of Sacsin fucntion. SacsR272C missense homozygous mice develop an ataxia phenotype published in the Molecular Brain. Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec vos amis:

View Post

Next Board meeting: June 5, 2019

In Activities by ARSACS

The next meeting of the Board of the Ataxia Charlevoix-Saguenay Foundation will be held in Montreal on Wednesday June 5,2019. Interesting, right? Share with your friends & followers / Intéressant, non? Partagez avec vos amis: